Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-choice immune tolerance induction with FVIII/VWF versus VWF-free FVIII in severe hemophilia A with high-risk inhibitors
2008-007016-15Phase 4Active
- Sponsor
- Fondazione Angelo Bianchi Bonomi
- Start
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in hemophilia A comparing VWF-free FVIII concentrate with FVIII/VWF concentrate (2 arms). Primary endpoint: Induction of immune tolerance to factor VIII. Started Mar 2009; status: active.
02
Drugs
Factor VIIIcoagulation factor VIII + von Willebrand factor
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2008-007016-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007016-15.